These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23734804)

  • 41. Circulating miRNA and cancer diagnosis.
    Tie Y; Liu B; Fu H; Zheng X
    Sci China C Life Sci; 2009 Dec; 52(12):1117-22. PubMed ID: 20016968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 43. Special series on comparative effectiveness research: challenges to real-world solutions to quality improvement in personalized medicine.
    Browman GP
    J Clin Oncol; 2012 Dec; 30(34):4188-91. PubMed ID: 23071250
    [No Abstract]   [Full Text] [Related]  

  • 44. Proteomic Approaches for Biomarker Panels in Cancer.
    Tanase C; Albulescu R; Neagu M
    J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics.
    Luna Coronell JA; Syed P; Sergelen K; Gyurján I; Weinhäusel A
    J Proteomics; 2012 Dec; 76 Spec No.():102-15. PubMed ID: 22842156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sensitive antibody-based CTCs detection from peripheral blood.
    Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):51-4. PubMed ID: 24284308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating tumour cells and circulating endothelial cells as biomarkers in oncology.
    Strijbos MH
    Acta Clin Belg; 2011; 66(5):332-6. PubMed ID: 22145267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune biomarkers: how well do they serve prognosis in human cancers?
    Baxevanis CN; Anastasopoulou EA; Voutsas IF; Papamichail M; Perez SA
    Expert Rev Mol Diagn; 2015 Jan; 15(1):49-59. PubMed ID: 25345403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cancer: three eras of personalized medicine].
    Jordan B
    Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Biomarker Harvest from One Thousand Cancer Cell Lines.
    Huang YH; Vakoc CR
    Cell; 2016 Jul; 166(3):536-537. PubMed ID: 27471963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncoproteomics: Trials and tribulations.
    Zhou L; Li Q; Wang J; Huang C; Nice EC
    Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liquid Profiling of Circulating Nucleic Acids as a Novel Tool for the Management of Cancer Patients.
    Holdenrieder S
    Adv Exp Med Biol; 2016; 924():53-60. PubMed ID: 27753019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?
    Diamandis EP
    BMC Med; 2012 Aug; 10():87. PubMed ID: 22876833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 55. Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics.
    Zamay AS; Zamay GS; Kolovskaya OS; Zamay TN; Berezovski MV
    Adv Exp Med Biol; 2017; 994():67-81. PubMed ID: 28560668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Latest discoveries and trends in translational cancer research: highlights of the 2008 Annual Meeting of the American Association for Cancer Research.
    Cho WC
    Technol Cancer Res Treat; 2008 Aug; 7(4):269-77. PubMed ID: 18642965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CANCER IMMUNOLOGY. The "cancer immunogram".
    Blank CU; Haanen JB; Ribas A; Schumacher TN
    Science; 2016 May; 352(6286):658-60. PubMed ID: 27151852
    [No Abstract]   [Full Text] [Related]  

  • 58. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Personalized Radiation Therapy (PRT) for Lung Cancer.
    Jin JY; Kong FM
    Adv Exp Med Biol; 2016; 890():175-202. PubMed ID: 26703805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
    Kamel HFM; Al-Amodi HSAB
    Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.